MW McCarthy - Expert Opinion on Pharmacotherapy, 2023 - europepmc.org
The optimal treatment of standard-risk outpatients who develop mild-to-moderate COVID-19
is controversial. While several therapeutic are currently recommended, including nirmatrelvir …